{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:42:05Z","timestamp":1789371725547,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS PharmSci"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1208\/ps010417","type":"journal-article","created":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T17:26:02Z","timestamp":1059758762000},"page":"5-13","source":"Crossref","is-referenced-by-count":28,"title":["Empirical versus mechanistic modelling: Comparison of an artificial neural network to a mechanistically based model for quantitative structure pharmacokinetic relationships of a homologous series of barbiturates"],"prefix":"10.1208","volume":"1","author":[{"given":"Ivan","family":"Nestorov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. T.","family":"Hadjitodorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1999,12,17]]},"reference":[{"key":"14005_CR1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4684-8053-5_3","volume-title":"New Trends in Pharmacokineties","author":"AK Thakur","year":"1991","unstructured":"Thakur AK, Model mechanistic vs empirical. In: Rescigno A, Thakur AK, eds. New Trends in Pharmacokineties. New York: Plenum Press. 1991; 41\u201351."},{"key":"14005_CR2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF01066325","volume":"15","author":"A Rescigno","year":"1987","unstructured":"Rescigno A, Beck JS (Comments: Thakur AK). The use and abuse of models. I Pharmacokinet Biopharm. 1987;15:327.","journal-title":"I Pharmacokinet Biopharm"},{"key":"14005_CR3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF01062465","volume":"20","author":"P Veng-Pedersen","year":"1992","unstructured":"Veng-Pedersen P, Modi NB. Neural networks in pharmacodynamic modeling: is current modeling practice of complex kinetic systems at a dead end? J Pharmacokinet Biopharm. 1992;20:397\u2013412.","journal-title":"J Pharmacokinet Biopharm"},{"key":"14005_CR4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF01062466","volume":"20","author":"RA Siegel","year":"1992","unstructured":"Siegel RA. Commentary on \u201cNeural networks in pharmacodynamic modeling: is current modeling practice of complex kinetic systems at a dead end?\u201d J Pharmacokinet Biopharm. 1992;20:413\u2013416.","journal-title":"J Pharmacokinet Biopharm"},{"key":"14005_CR5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF01062467","volume":"20","author":"P Veng-Pedersen","year":"1992","unstructured":"Veng-Pedersen P. Response to Siegel's commentary. J Pharmacokinet Biopharm. 1992;20:417\u2013418.","journal-title":"J Pharmacokinet Biopharm"},{"key":"14005_CR6","first-page":"311","volume-title":"Pharmacokinetics: Theory and Methodology International Encyclopedia of Pharmacology and Therapeutics, Section 122","author":"JK Seydel","year":"1986","unstructured":"Seydel JK, Schaper K-J. Quantitative structure-pharmacokinetic relationships and drug design. In: Rowland M, Tucker G, eds. Pharmacokinetics: Theory and Methodology International Encyclopedia of Pharmacology and Therapeutics, Section 122, Oxford: Pergamon Press, 1986;311\u2013368."},{"key":"14005_CR7","volume-title":"Neural Computing, Theory and Practice","author":"PD Wasserman","year":"1989","unstructured":"Wasserman PD. Neural Computing, Theory and Practice. New York: Van Nostrand Reinhold, 1989."},{"key":"14005_CR8","volume-title":"Neural Networks. A Comprehensive Foundation","author":"S Haykin","year":"1994","unstructured":"Haykin S. Neural Networks. A Comprehensive Foundation. Toronto: Maxwell Macmillan Canada, 1994."},{"key":"14005_CR9","volume-title":"Neurocomputing","author":"R Heicht-Nielsen","year":"1990","unstructured":"Heicht-Nielsen R. Neurocomputing, Reading, MA: Addison Wesley, 1990."},{"key":"14005_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1109\/2.485891","volume":"29","author":"AK Jain","year":"1996","unstructured":"Jain AK, Mao J, Mohiuddin KM. Artificial neural networks: a tutorial. Computer 1996;29:31\u201344.","journal-title":"Computer"},{"key":"14005_CR11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1109\/2.485892","volume":"29","author":"Y Shang","year":"1996","unstructured":"Shang Y, Wah BW. Global optimisation for neural network training. Computer. 1996;29:45\u201355.","journal-title":"Computer"},{"key":"14005_CR12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1018966222807","volume":"10","author":"RJ Erb","year":"1993","unstructured":"Erb RJ. Introduction to backpropagation neural network computation. Pharm Res. 1993;10:165\u2013170.","journal-title":"Pharm Res"},{"key":"14005_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00003088-199529020-00002","volume":"29","author":"RJ Erb","year":"1995","unstructured":"Erb RJ. The backpropagation neural network-;a Bayesian classifier. Introduction and applicability to pharmacokinetics. Clin Pharmacokinet. 1995;29:69\u201379.","journal-title":"Clin Pharmacokinet"},{"key":"14005_CR14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jps.2600820910","volume":"82","author":"P Veng-Pedersen","year":"1993","unstructured":"Veng-Pedersen P, Modi NB. Neural networks in pharmacodynamic modeling. J Pharm Sci. 1993;82:918\u2013926.","journal-title":"J Pharm Sci"},{"key":"14005_CR15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0009-9236(95)90224-4","volume":"57","author":"ME Brier","year":"1995","unstructured":"Brier ME. Neural network gentamicin peak and trough predictions from prior dosing data. Clin Pharm Ther. 1995;57:157.","journal-title":"Clin Pharm Ther"},{"key":"14005_CR16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1023\/A:1016260720218","volume":"12","author":"ME Brier","year":"1995","unstructured":"Brier ME, Zurada JM, Aronoff GR. Neural network predicted peak and trough gentamicin concentrations. Pharm Res. 1995;12:406\u2013412.","journal-title":"Pharm Res"},{"key":"14005_CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0009-9236(95)90224-4","volume":"57","author":"ME Brier","year":"1995","unstructured":"Brier ME, Aronoff GR. Neural network predictions of cyclosporine A blood concentration. Clin Pharm Ther. 1995;57:157.","journal-title":"Clin Pharm Ther"},{"key":"14005_CR18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1021\/js950271l","volume":"85","author":"BP Smith","year":"1996","unstructured":"Smith BP, Brier ME. Statistical approach to network model building for gentamicin peak predictions. J Pharm Sci. 1996;85:65\u201369.","journal-title":"J Pharm Sci"},{"key":"14005_CR19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1023\/A:1016283930696","volume":"12","author":"L Gobburu","year":"1995","unstructured":"Gobburu L, Kumar K, Shelver WH. Prediction of alfentanil plasma concentrations using artificial neural networks (ANN). Pharm Res. 1995;12(Suppl):S329.","journal-title":"Pharm Res"},{"key":"14005_CR20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1023\/A:1016260720218","volume":"12","author":"ME Brier","year":"1995","unstructured":"Brier ME. Empirical pharmacokinetic predictions for cyclosporine using a time series neural network. Pharm Res. 1995;12(Suppl.):S363.","journal-title":"Pharm Res"},{"key":"14005_CR21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1023\/A:1016260720218","volume":"12","author":"ME Brier","year":"1995","unstructured":"Brier ME. Empirical pharmacokinetic predictions using neural network, generalized linear, and generalized additive models. Pharm Res. 1995;12 Suppl.:S363.","journal-title":"Pharm Res"},{"key":"14005_CR22","first-page":"510","volume":"34","author":"ME Brier","year":"1996","unstructured":"Brier ME, Aronoff GR. Application of artificial neural networks to clinical pharmacology. Int J Clin Pharm Ther. 1996;34:510\u2013514.","journal-title":"Int J Clin Pharm Ther"},{"key":"14005_CR23","first-page":"328","volume":"12","author":"BP Smith","year":"1995","unstructured":"Smith BP, Brier ME. Empirical pharmacodynamic predictions using neural networks: Comparison to NONMEM. Pharm Res. 1995;12 Suppl.:S328.","journal-title":"Pharm Res"},{"key":"14005_CR24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/js950433d","volume":"85","author":"J Gobburu","year":"1996","unstructured":"Gobburu J, Chen EP. Artificial neural networks as a novel approach to integrated pharmacokinetic-; pharmacodynamic analysis. J Pharm Sci. 1996;85:505\u2013510.","journal-title":"J Pharm Sci"},{"key":"14005_CR25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1023\/A:1016213721861","volume":"12","author":"K Kumar","year":"1995","unstructured":"Kumar K, Gobburu JVS, Ballantyne JA, Shelver WH. Population pharmacokinetic parameter prediction with artificial neural networks (ANN). Pharm Res. 1995;12 Suppl.:S329.","journal-title":"Pharm Res"},{"key":"14005_CR26","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1021\/js9604016","volume":"86","author":"H-H Chow","year":"1997","unstructured":"Chow H-H, Tolle KM, Row DJ, Elsberry V, Chen H. Application of neural networks to population pharmacokinetic data analysis. J Pharm Sci. 1997;86:840\u2013845.","journal-title":"J Pharm Sci"},{"key":"14005_CR27","first-page":"364","volume":"12","author":"J Gobburu","year":"1995","unstructured":"Gobburu J, Shelver WH. Feasibility of artificial neural network application to derive in-vivo characteristics in a congeneric series of compounds. Pharm Res. 1995;12 Suppl.:S364.","journal-title":"Pharm Res"},{"key":"14005_CR28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4684-6036-0_12","volume-title":"In Vitro-;In Vivo Correlations","author":"AS Hussain","year":"1997","unstructured":"Hussain AS. Artificial neural networks based in vitro-in vivo correlations. In: Young D, ed. In Vitro-;In Vivo Correlations. New York: Plenum Press, 1997;149\u2013158."},{"key":"14005_CR29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-4684-6036-0_22","volume-title":"In vitro-;in vivo correlations","author":"JA Dowell","year":"1997","unstructured":"Dowell JA, Hussain AS, Stark P, Devane J, Young D Development of in vitro-;in vivo correlations using various artificial neural network configurations. In: Young D, ed. In vitro-;in vivo correlations. New York: Plenum Press, 1997;225\u2013239."},{"key":"14005_CR30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1023\/A:1018917128684","volume":"10","author":"AS Hussain","year":"1993","unstructured":"Hussain AS, Johnson RD, Vachharajani NN, Ritschel WA. Feasibility of developing a neural network for prediction of human pharmacokinetic parameters from animal data. Pharm Res. 1993;10:466\u2013469.","journal-title":"Pharm Res"},{"key":"14005_CR31","first-page":"629","volume":"17","author":"WA Ritschel","year":"1995","unstructured":"Ritschel WA, Akileswaran R, Hussain AS. Application of neural networks for the prediction of human pharmacokinetic parameters. Meth Find Exp Clin Pharmacol. 1995;17:629\u2013643.","journal-title":"Meth Find Exp Clin Pharmacol"},{"key":"14005_CR32","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/jps.2600840715","volume":"84","author":"J Gobburu","year":"1995","unstructured":"Gobburu J, Shelver WH. Quantitative structure-pharmacokinetic relationship (QSPR) of beta blockers derived using neural networks. J Pharm Sci. 1995;84:862\u2013865.","journal-title":"J Pharm Sci"},{"key":"14005_CR33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1023\/A:1025771608474","volume":"25","author":"GE Blakey","year":"1997","unstructured":"Blakey GE, Nestorov IA, Arundel PA, Aarons LJ, Rowland M. Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat. J Pharmacokin Biopharm. 1997;25:277\u2013312.","journal-title":"J Pharmacokin Biopharm"},{"key":"14005_CR34","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1023\/A:1023221116200","volume":"26","author":"IA Nestorov","year":"1998","unstructured":"Nestorov IA, Aarons LJ, Rowland M. Quantitative structure-pharmacokinetics relationships: II. A mechanistically based model to evaluate the relationship between tissue distribution parameters and compound lipophilicity. J Pharmacokin Biopharm. 1998;26:521\u2013545.","journal-title":"J Pharmacokin Biopharm"},{"key":"14005_CR35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","volume":"9","author":"LB Sheiner","year":"1981","unstructured":"Sheiner LB, Beal S. Some suggestions for measuring predictive performance. J Pharmacokin Biopharm. 1981;9:503\u2013512.","journal-title":"J Pharmacokin Biopharm"},{"key":"14005_CR36","unstructured":"ACSL Reference Manual, Edition 11. MGA Software, Concord MA 01742, USA, 1995."},{"key":"14005_CR37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1025740909016","volume":"25","author":"I Nestorov","year":"1997","unstructured":"Nestorov I, Aarons L, Rowland M. Physiologically based pharmacokinetic modelling of a homologous series of barbiturates: a sensitivity analysis. J Pharmacokin Biopharm. 1997;25:413\u2013447.","journal-title":"J Pharmacokin Biopharm"},{"key":"14005_CR38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0167-6393(97)00004-6","volume":"21","author":"S Hadjitodorov","year":"1997","unstructured":"Hadjitodorov S, Boyanov B, Dalakchieva N. A two-level classifier for text-independent speaker identification. Speech Communication. 1997;21:209\u2013217.","journal-title":"Speech Communication"},{"key":"14005_CR39","unstructured":"Neural Network Toolbox for use with MATLAB. The Mathworks Inc., Natick MA 01760-1500, USA, 1998.A."}],"container-title":["AAPS PharmSci"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/ps010417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/ps010417\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/ps010417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T23:41:55Z","timestamp":1559605315000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/ps010417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["14005"],"URL":"https:\/\/doi.org\/10.1208\/ps010417","relation":{},"ISSN":["1522-1059"],"issn-type":[{"value":"1522-1059","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}